retatrutide clinical trial thailand & GLP-1 in – Expat guide 2026 Retatrutide in Bangkok | H.U.M.

We want to emphasize that the decision to prescribe Semaglutide GLP-1 is not based solely on BMI

Tirzepatide may be suitable for adults who are classified as obese, with a body mass index (BMI) of 30 or higher, or those who are overweight with a BMI of 27 or higher and have related health conditions such as hypertension, type 2 diabetes, or dyslipidemia

Saxenda (liraglutide) Saxenda is another GLP1 drug, approved for daily use in weight management

To find out whether youre a candidate, start your eligibility assessment here

DOSAGE AND ADMINISTRATION : DOSAGE FORMS AND STRENGTHS : Solution for subcutaneous injection, pre-filled, multi-dose pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg (6 mg/mL, 3 mL) CONTRAINDICATIONS : Do not use in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2

Another may be a diagnosis or BMI threshold written into the health plan